Mangoceuticals, Inc.
MGRX Healthcare Health Information Services
Mangoceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $456,000.00, down 26.0% from fiscal 2024. In the quarter to June 2026, revenue fell 59.1%, EPS grew 84.2% and free cash flow grew 79.3%, each against the same quarter a year earlier.
Follow MGRX
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
1.49 | 0.06 | 0.74 | 0.68 | 0.02 |
Inventory |
— | — | 0.02 | — | — |
Other current assets |
0.05 | 0.02 | 0.02 | 0.01 | — |
Total current assets |
1.55 | 0.08 | 0.84 | 0.69 | 0.02 |
Property, Plant, Equpment (Net) |
0.00 | 0.00 | 0.10 | 0.12 | — |
Goodwill and Intangible Assets (Total) |
14.23 | 15.23 | — | — | — |
Long-term assets (Other) |
— | — | — | 0.02 | — |
Total non-current assets |
14.54 | 15.29 | 0.22 | 0.31 | — |
Total Assets |
16.09 | 15.37 | 1.05 | 1.00 | 0.02 |
Notes Payable |
— | 0.15 | — | 0.17 | 0.04 |
Accounts Payable |
0.42 | 0.84 | 0.14 | 0.03 | — |
Other current liabilities |
0.17 | 0.37 | 0.01 | 0.00 | — |
Total current liabilities |
0.89 | 1.43 | 0.21 | 0.26 | 0.04 |
Total non-current liabilities |
— | — | 0.07 | 0.13 | — |
Total liabilities |
0.89 | 1.43 | 0.28 | 0.39 | 0.04 |
Additional Paid In Capital |
55.52 | 34.79 | 12.00 | 2.63 | 0.00 |
Preferred Stock (Total) |
0.00 | 0.00 | — | — | — |
Common Stock (Net) |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Retained Earnings |
(40.65) | (20.00) | (11.23) | (2.02) | (0.02) |
Shareholders Equity (Other) |
0.32 | (0.83) | — | — | — |
Common Equity (Total) |
15.20 | 13.95 | 0.77 | 0.61 | (0.02) |
Shareholders Equity (Total) |
15.20 | 13.95 | 0.77 | 0.61 | (0.02) |
Shareholders Equity and Liabilities (Total) |
16.09 | 15.37 | 1.05 | 1.00 | 0.02 |
Shares (Common) |
15.89 | 3.25 | 1.43 | 0.89 | 0.53 |
Shares (Preferred) |
0.98 | 0.98 | — | — | — |
Shareholders Equity (Tangible) |
0.97 | (1.29) | 0.77 | 0.61 | (0.02) |
Net Debt |
(1.49) | (0.06) | (0.74) | (0.68) | (0.02) |
Total Debt |
— | — | — | 0.35 | 0.04 |